Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;119(1-3):47-51.
doi: 10.1016/j.schres.2009.12.035. Epub 2010 Jan 21.

Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia

Ripu D Jindal  1 , Anil K Pillai, Sahebrao P Mahadik, Kevin Eklund, Debra M Montrose, Matcheri S Keshavan
Affiliations

Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia

Ripu D Jindal et al. Schizophr Res. 2010 Jun.

Abstract

Objective: Brain-derived neurotrophic factor (BDNF) is a key factor known to mediate neuronal proliferation, differentiation, survival and response to stress. Decreases in BDNF levels have been reported in schizophrenia, but studies in treatment naïve patients are few. Herein we report on serum BDNF levels in a series of patients with first-episode treatment naïve psychoses in comparison to age matched healthy controls.

Method: Fasting serum BDNF levels were measured in 41 patients with treatment naive first episode psychosis (24 with schizophrenia, schizoaffective disorder or schizophreniform disorder, and 17 with non-schizophrenia psychotic disorders) and 41 age-matched healthy controls.

Results: A three group analyses of covariance (ANCOVA) showed a diagnosis effect (p=.038) in which patients with schizophrenia had lesser serum BDNF levels than patient with non-schizophrenia psychosis, who in turn had lesser BDNF levels than matched healthy controls. Planned two-group ANCOVAs suggested that patients with schizophrenia had lower serum BDNF level than matched controls (p=.016), whereas patients with non-schizophrenia psychosis did not differ from controls. There were no age effects on BDNF, but there was a trend (p=.08) for a gender by group interaction with greater reductions in female patients with schizophrenia. The BDNF levels did not correlate with magnitude of smoking, body mass index, severity of positive and negative symptoms or overall functioning.

Conclusions: Serum BDNF may be reduced at the onset of psychosis but its role in the pathogenesis of schizophrenia remains unclear. Elucidating the role of BDNF in schizophrenia and related psychotic disorders may provide an important therapeutic target. Further studies are also needed to examine if patients with schizophrenia have more pronounced reductions in BDNF than those with affective psychosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scatterplot showing serum BDNF levels (pg/mL) in first episode schizophrenia, healthy controls and non-schizophrenia psychosis patients. Boxes represent standard deviations.
See this image and copyright information in PMC

References

    1. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 1997;389:856–860. - PubMed
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4. Washington, DC: American Psychiatric Press; 1994.
    1. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS) Iowa City: IA: University of Iowa; 1983.
    1. Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS) Iowa City: IA: University of Iowa; 1984.
    1. Angelucci F, Aloe L, Iannitelli A, Gruber SH, Mathe AA. Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain. Eur Neuropsychopharmacol. 2005;15:311–317. - PubMed

Publication types

Substances